Arcutis Biotherapeutics Inc (ARQT) Insider Trading
- $26,622,082.75
- $26,018,369.68
- May 28, 2025
- Todd Franklin Watanabe
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
May 28, 2025 | Insider | 1,800 | $13.78 | Sell | $24,804.00 | |
May 21, 2025 | Director | 2,520 | $13.66 | Buy | $34,423.20 | |
May 19, 2025 | Insider | 7,451 | $14.07 | Sell | $104,835.57 | |
May 8, 2025 | Insider | 3,871 | $13.59 | Sell | $52,606.89 | |
May 2, 2025 | Insider | 5,030 | $15.20 | Sell | $76,456.00 | |
March 24, 2025 | Insider | 1,500 | $17.52 | Sell | $26,280.00 | |
March 17, 2025 | Insider | 1,200 | $17.61 | Sell | $21,132.00 | |
March 14, 2025 | Insider | 12,242 | $15.04 | Sell | $184,119.68 | |
March 3, 2025 | Insider | 2,819 | $13.03 | Sell | $36,731.57 | |
March 3, 2025 | Director | 10,000 | $13.00 | Sell | $130,000.00 | |
Feb. 3, 2025 | Insider | 8,338 | $12.70 | Sell | $105,892.60 | |
Feb. 3, 2025 | Director | 10,000 | $12.71 | Sell | $127,100.00 | |
Jan. 2, 2025 | Director | 10,000 | $14.67 | Sell | $146,700.00 | |
Dec. 31, 2024 | Insider | 1,691 | $14.00 | Sell | $23,674.00 | |
Dec. 20, 2024 | Insider | 15,000 | $15.17 | Sell | $227,550.00 | |
Dec. 2, 2024 | Director | 10,000 | $12.51 | Sell | $125,100.00 | |
Nov. 30, 2024 | Insider | 1,093 | $7.11 | Buy | $7,771.23 | |
Nov. 22, 2024 | Insider | 16,023 | $10.14 | Sell | $162,473.22 | |
Nov. 19, 2024 | Insider | 1,775 | $9.68 | Sell | $17,182.00 | |
Nov. 15, 2024 | Insider | 100 | $10.03 | Sell | $1,003.00 | |
Nov. 11, 2024 | Director | 8,687 | $10.85 | Sell | $94,253.95 | |
Nov. 4, 2024 | Insider | 5,015 | $8.68 | Sell | $43,530.20 | |
Nov. 1, 2024 | Director | 10,000 | $8.65 | Sell | $86,500.00 | |
Oct. 2, 2024 | SVP | 3,725 | $10.01 | Sell | $37,287.25 | |
Oct. 1, 2024 | Director | 10,000 | $9.26 | Sell | $92,600.00 | |
Sept. 24, 2024 | CFO | 11,626 | $9.48 | Sell | $110,214.48 | |
Sept. 3, 2024 | Director | 10,000 | $10.77 | Sell | $107,700.00 | |
Aug. 19, 2024 | Insider | 1,728 | $8.29 | Sell | $14,325.12 | |
Aug. 2, 2024 | Insider | 5,220 | $9.02 | Sell | $47,084.40 | |
Aug. 1, 2024 | Director | 10,000 | $9.87 | Sell | $98,700.00 | |
July 1, 2024 | Director | 10,000 | $9.31 | Sell | $93,100.00 | |
May 30, 2024 | Insider | 23,000 | $8.75 | Sell | $201,250.00 | |
May 28, 2024 | Insider | 1,775 | $9.01 | Sell | $15,992.75 | |
May 17, 2024 | SVP | 7,640 | $8.98 | Sell | $68,607.20 | |
March 4, 2024 | Insider | 3,760 | $11.12 | Sell | $41,811.20 | |
Jan. 2, 2024 | Insider | 1,325 | $3.54 | Sell | $4,690.50 | |
Nov. 21, 2023 | Insider | 1,850 | $1.98 | Sell | $3,663.00 | |
Oct. 24, 2023 | Major Shareholder | 80,000 | $2.50 | Buy | $200,000.00 | |
Aug. 21, 2023 | Insider | 1,605 | $7.04 | Sell | $11,299.20 | |
May 31, 2023 | Insider | 1,830 | $7.80 | Sell | $14,274.00 | |
April 17, 2023 | Director | 8,500 | $13.97 | Sell | $118,745.00 | |
April 6, 2023 | Director | 8,500 | $12.01 | Sell | $102,085.00 | |
March 6, 2023 | SVP | 831 | $15.26 | Sell | $12,681.06 | |
March 6, 2023 | Insider | 2,435 | $15.26 | Sell | $37,158.10 | |
March 6, 2023 | CFO | 291 | $15.26 | Sell | $4,440.66 | |
March 2, 2023 | Insider | 5,472 | $15.83 | Sell | $86,621.76 | |
March 2, 2023 | CFO | 1,434 | $15.83 | Sell | $22,700.22 | |
March 2, 2023 | SVP | 1,432 | $15.83 | Sell | $22,668.56 | |
Feb. 28, 2023 | Insider | 2,343 | $16.17 | Sell | $37,886.31 | |
Feb. 28, 2023 | CFO | 416 | $16.17 | Sell | $6,726.72 |
Insiders are both buying and selling Arcutis Biotherapeutics Inc stock.
The insider traders at Arcutis Biotherapeutics Inc are: Todd Franklin Watanabe, Howard G Welgus, Patrick Burnett, Masaru Matsuda, Bhaskar Chaudhuri, Scott L Burrows, John W. Smither, Larry Todd Edwards, Patricia A Turney, Orbimed Advisors Llc, Life Sciences Viii L Frazier, OSBORNE DAVID W, Howard G. Welgus, David W Osborne, Patrick J Heron, Welgus Howard G., Terrie Curran, David Joseph Topper, Jonathan Silverstein, Watanabe Todd Franklin, and David W. Osborne
The most active insider trader at Arcutis Biotherapeutics Inc is Todd Franklin Watanabe with 31 trades.
Orbimed Advisors Llc has sold the most Arcutis Biotherapeutics Inc stock with a total value of $25,610,794.78.
Jonathan Silverstein has bought the most Arcutis Biotherapeutics Inc stock with a total value of $28,659,776.64.
The most recent insider trade for Arcutis Biotherapeutics Inc was on May 28, 2025.
The single biggest insider buy for Arcutis Biotherapeutics Inc was from Jonathan Silverstein with a total value of $14,329,888.32 on Feb. 3, 2020.
The single biggest insider sell for Arcutis Biotherapeutics Inc was from Orbimed Advisors Llc with a total value of $7,287,402.01 on June 24, 2022.